THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
91,996,558
Share change
+22,346,257
Total reported value
$580,382,712
Price per share
$6.31
Number of holders
81
Value change
+$141,497,858
Number of buys
63
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2014

As of 31 Mar 2014, THERAPEUTICSMD INC - COM (TXMD) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 91,996,558 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, FMR LLC, RA CAPITAL MANAGEMENT, LLC, GILDER GAGNON HOWE & CO LLC, Bank of New York Mellon Corp, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, VANGUARD GROUP INC, and Partner Fund Management, L.P.. This page lists 81 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.